Auxly Receives Conditional Approval to Graduate to the Toronto Stock Exchange
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company"),...
Year: 2021
Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile
Avicanna has been granted its 2021 quota from the Colombian government to cultivate and process up to 10,267 kg of...
Todos Medical Completes Automation Equipment Installation and Training for a Laboratory Client in Brooklyn, NY
· Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades · Client...
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing Leaders
SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
Algernon Pharmaceuticals Announces its Addition to the Market’s First Psychedelic Stock Index ETF
VANCOUVER, British Columbia., March 29, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Precision BioSciences to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Day
DURHAM, N.C., March 29, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic...
Psirenity granted approval to conduct Jamaica’s first psilocybin clinical trial to help manage depression
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Psirenity, a wholly owned subsidiary of New Leaf Canada Inc., today announced it...
Clene Reports Full Year 2020 Operating and Financial Highlights
Interim Phase 2 data indicate that CNM-Au8 has a homeostatic effect on brain bioenergetics Topline data from a Phase 2...
Cerecor Announces New Worldwide License Agreement with Kyowa Kirin for Anti-LIGHT Antibody CERC-002
Expanded agreement for exclusive, world-wide rights to develop, manufacture and commercialize CERC-002 for all indications including severe pediatric onset inflammatory...
Imara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders
Company will award grants totaling up to $150,000 to nonprofit community-based organizations that support sickle cell disease and beta-thalassemia patients...
Gritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in Phase 1 Study Conducted and Supported by NIAID/IDCRC
– Preliminary Data from Phase 1 Study of CORAL Expected Mid-year – – Study will Assess Antibody and CD8+ T...
Syneos Health Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity
Science 37’s Technology-First Operating System Further Powers Syneos Health’s Decentralized SolutionsMORRISVILLE, N.C. and LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- Syneos...
Fifteen Medical Societies Now Recommend Icosapent Ethyl to Reduce Cardiovascular Risk, Further Supporting that VASCEPA® is Rapidly Becoming a New Standard of Care
Recent recommendations or guidances, from Canada and Egypt, expand the global recognition of this important therapy and its demonstrated favorable...
Progressive Care Announces Annual Audited 2020 Report Earnings Call and Business Update on April 1st, 2021
MIAMI, FL, March 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care,” the “Company,”...
I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates
18 significant clinical milestones achieved since the Company’s IPO in January 2020, with multiple important data readouts for lemzoparlimab (TJC4),...
Akouos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
- In 2020, continued to advance genetic medicine pipeline with execution of IND-enabling studies for AK-OTOF and general alignment with...
Myovant Sciences Announces European Medicines Agency Validation of Marketing Authorization Application for Relugolix for the Treatment of Advanced Prostate Cancer
If approved, relugolix would be the first and only oral androgen deprivation therapy for advanced prostate cancer in EuropeRelugolix is...
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
First and only tongue-delivered neuromodulation therapy provides new treatment option for U.S. patients living with gait deficit due to symptoms...
Erasca Appoints Bihua Chen and Julie Hambleton, M.D., to its Board of Directors
Ms. Chen, portfolio manager at Cormorant Asset Management, and Dr. Hambleton, a physician-turned-biotech executive, bring decades of experience to their...
PaceMate™ Closes Series A Financing to Accelerate Growth
BRADENTON, Fla.--(BUSINESS WIRE)--#EPeeps--PaceMate™, the leading digital healthcare company in compliant cardiac data management, is pleased to announce a recent $8...